SS&C Intralinks Success Stories
We’ve helped clients in nearly every country and industry throughout the world with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.
Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.
£1.8 billion
Holland & Barrett Retail, Europe’s largest health and wellness retailer, used Intralinks for its acquisition by L1 Retail from The Carlyle Group for £1.8 billion.
USD 1.1 billion
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its PARAGARD® intrauterine device business to CooperSurgical for USD 1.1 billion.
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its PARAGARD® intrauterine device business to CooperSurgical for USD 1.1 billion.
SEK 108.3 billion
Atlas Copco, a Sweden-based global manufacturer and supplier of industrial products and solutions, used Intralinks for the spin-off of Epiroc, its mining and infrastructure equipment business, to shareholders, valuing Epiroc at SEK 108.3 billion.
€24.0 billion
Essilor, a listed France-based world leader in ophthalmic optics, used Intralinks for its merger with Luxottica, a listed Italian-based leader in fashion, luxury and sports eyewear, valuing Luxottica at €24.0 billion.
€8.3 billion
Zodiac Aerospace, a listed France-based manufacturer of aerospace equipment and systems, used Intralinks for its acquisition by Safran for €8.3 billion.
USD 7.1 billion
Frutarom, a listed Israel-based global developer, manufacturer and marketer of flavours and natural fine ingredients, used Intralinks for its acquisition by International Flavors & Fragrances for USD 7.1 billion.
USD 105 million
Alliance Residential used Intralinks for its acquisition by The Connor Group for a total USD 105 mil.
USD 3.9 billion
Advanced Accelerator Applications, a listed France-based radiopharmaceutical company developing, producing and commercializing molecular nuclear medicine therapeutic and diagnostic products, used Intralinks for its acquisition by Novartis for USD 3.9 billion.
USD 2.0 billion
Alliance Automotive Group,
a leading European motor vehicle supplies and parts distributor, used Intralinks for its acquisition by Genuine Parts Company from Blackstone Group for USD 2.0 billion.
a leading European motor vehicle supplies and parts distributor, used Intralinks for its acquisition by Genuine Parts Company from Blackstone Group for USD 2.0 billion.
USD 550 million
Momondo Group,
a UK-based provider of online travel agency services, used Intralinks in its acquisition by The Priceline Group from Great Hill Partners for USD 550 million.
a UK-based provider of online travel agency services, used Intralinks in its acquisition by The Priceline Group from Great Hill Partners for USD 550 million.
USD 1.9 billion
Netafim, an Israel-based provider of smart irrigation solutions, used Intralinks in its majority acquisition by Mexichem from Permira, Kibbutz Magal & Kibbutz Hatzerim for USD 1.9 billion.
USD 1.1 billion
NeuroDerm,
an Israel-based pharmaceutical firm developing next-generation treatments for central nervous system disorders, used Intralinks for its acquisition by Mitsubishi Tanabe Pharma Corporation for USD 1.1 billion.
an Israel-based pharmaceutical firm developing next-generation treatments for central nervous system disorders, used Intralinks for its acquisition by Mitsubishi Tanabe Pharma Corporation for USD 1.1 billion.
USD 675 million
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its emergency contraception brands portfolio to Foundation Consumer Healthcare for USD 675 million.
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its emergency contraception brands portfolio to Foundation Consumer Healthcare for USD 675 million.
170 millions de dollars (USD)
Silva International Inc. used Intralinks in connection with its acquisition by Universal Corp for a total value of USD 170 million dollars in cash.
USD 900 million
African Development Partners III is the firm's third growth fund dedicated to investments in companies serving Africa's middle class.
USD 1.89 billion
Eurazeo Growth Fund III will assist fast-growing companies in technology sectors by setting up the necessary financial and human resources for their development and the completion of transformation projects.
USD 100 million
Oriens Capital Private Equity Fund 2 is the second fund in its series. The fund focuses on mid-market opportunities in regional New Zealand.
£$275 million
True Capital seeks to invest in UK-headquartered, lower-mid market businesses operating in the consumer products and services sector.